U.S. Treasury Secretary Scott Bessent discusses the economic outlook for America on 'Kudlow.' ...
BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of ...
Assessment of proteinuria in addition to estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD) may help identify individuals at high risk of adverse outcomes ...
Sexual intercourse can cause proteinuria in men for up to 12 h, according to a small prospective study at the Israel Naval Medical Institute. When dipstick urine tests are positive for protein ...
The following is a summary of “Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy,” published in the ...
Dear Dr. Fritz,Good day. Please call me Freezee. I am quite anxious because I see my urine is foamy. Why is this happening? Would this mean, that I am sick of s ...
About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) vs percutaneous transhepatic biliary drainage (PTBD) for cholangiocarcinoma biliary obstruction: An updated systematic ...
Biocity Biopharmaceutics Co. Ltd.’s selective endothelin receptor type A antagonist, SC-0062, met the primary endpoint of reducing proteinuria in a phase II diabetic kidney disease cohort. Conducted ...